Bakar Bio Labs News - Bakar Bio Labs

Marco Lobba and Sophia Lugo Named to San Francisco Business Times 40 Under 40

Many people don’t end up in the jobs they wanted when they were four years old. But Catena Biosciences CEO Marco Lobba and Radar Therapeutics CEO Sophia Lugo aren’t most people — a fact that didn’t escape the San Francisco Business Times. For their innovative contributions to biotech and precision medicine — Lobba with CatenaBio’s Multi-Payload Conjugate™ antibody-drug combinations, Lugo with Radar’s targeted mRNA therapies — the SF Business Times named both Lobba and Lugo to their 2025 “40 Under 40” class of honorees, recognizing them as two of the most influential and industrious leaders in the Bay Area. The awards will be presented on Friday, April 25 at the Westin St. Francis in San Francisco.

Latest news²³

Decorative graphic with wording "Golden Ticket Competition"

Bakar Labs and the Cystic Fibrosis Foundation Support Entrepreneurs to Develop New Genetic Therapies for CF

Up to 3 selected companies will win "Golden Tickets" for lab space at Bakar Labs, and access to the extensive resources of the CF Foundation, including scientific experts and advice, lab/research tools and techniques, an extensive patient registry, clinical trial design support, and a Therapeutics Development Network of over 90 clinical trial sites in the US. Read post

Bakar Bio Labs News Affiliate News

Bakar Labs Partners with Wilson Sonsini to Provide Corporate and Intellectual Property Legal Services to Incubator Tenants

Wilson Sonsini’s goal is to improve the ecosystem for incubator tenants, achieving more equitable engagement, and expanding access to financial and other resources. Read post